Panaxia and Neuraxpharm to enter new medical cannabis markets in Europe
Both companies will expand their cooperation through the distribution of medical cannabis products in the highly attractive Czech and Swiss markets October 29, 2022 | Yhaoo!
Both companies will expand their cooperation through the distribution of medical cannabis products in the highly attractive Czech and Swiss markets October 29, 2022 | Yhaoo!
July 29, 2022 | The Malta Independent An Israeli medical cannabis company, Panaxia, has announced a €6 million investment and is set to deepen its connection with
May 19, 2022 | Yahoo! Finance Following the adaptation of the European production standard EU-GMP, Panaxia will start production in the local facility in Malta. Obtaining the
April 5, 2022 | BENZINGA – Net Israeli revenues in 2021 increased 38% to 83.6 million. – Initial revenues from medical cannabis oils export from Israel, which
January 3, 2022 | BENZINGA Panaxia Global (TASE: PNAX), which owns medical cannabis company Panaxia Labs Israel Ltd., has obtained official authorization from the EU Health Authority for the EU-GMP standard